Gerhard Piendl
Franz Josef Strauß Allee 11
Regensburg, BY 93053, Germany
Regensburg, BY 93053, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor Mice.
Journal: International journal of molecular sciences
Published: May 27, 2024
Protein kinase C targeting of luminal (T-47D), luminal/HER2-positive (BT474), and triple negative (HCC1806) breast cancer cells in-vitro with AEB071 (Sotrastaurin) is efficient but mediated by subtype specific molecular effects.
Journal: Archives of gynecology and obstetrics
Published: November 17, 2021
Differential Expression of PD-L1 during Cell Cycle Progression of Head and Neck Squamous Cell Carcinoma.
Journal: International journal of molecular sciences
Published: November 04, 2021
Buparlisib modulates PD-L1 expression in head and neck squamous cell carcinoma cell lines.
Journal: Experimental cell research
Published: May 26, 2020
A novel rabbit derived anti-HER2 antibody with pronounced therapeutic effectiveness on HER2-positive breast cancer cells in vitro and in humanized tumor mice (HTM).
Journal: Journal of translational medicine
Published: May 18, 2020
Differential localization of PD-L1 and Akt-1 involvement in radioresistant and radiosensitive cell lines of head and neck squamous cell carcinoma.
Journal: Carcinogenesis
Published: August 28, 2019
The Aurora-Kinase A Phe31-Ile polymorphism as possible predictor of response to treatment in head and neck squamous cell carcinoma.
Journal: Oncotarget
Published: February 06, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026